Progressive cervical cord atrophy parallels cognitive decline in Alzheimer’s disease
Alzheimer's disease (AD) is characterized by progressive episodic memory dysfunction. A prominent hallmark of AD is gradual brain atrophy. Despite extensive research on brain pathology, the understanding of spinal cord pathology in AD and its association with cognitive decline remains understudied. We analyzed serial magnetic resonance imaging (MRI) scans from the ADNI data repository to assess whether progressive cord atrophy is associated with clinical worsening. Cervical cord morphometry was measured in 45 patients and 49 cognitively normal controls (CN) at two time points over 1.5 years. Regression analysis examined associations between cord atrophy rate and cognitive worsening. Cognitive and functional activity performance declined in patients during follow-up. Compared with controls, patients showed a greater rate of decline of the anterior-posterior width of the cross-sectional cord area per month (- 0.12%, p = 0.036). Worsening in the mini-mental state examination (MMSE), clinical dementia rating (CDR), and functional assessment questionnaire (FAQ) was associated with faster rates of cord atrophy (MMSE: r = 0.320, p = 0.037; CDR: r = - 0.361, p = 0.017; FAQ: r = - 0.398, p = 0.029). Progressive cord atrophy occurs in AD patients; its rate over time being associated with cognitive and functional activity decline.
Authors
- Paul Gerson Unschuld (ORCID: https://orcid.org/0000-0002-6116-3386)
- Patrick Freund (ORCID: https://orcid.org/0000-0002-4851-2246)
- Tim Emmenegger (ORCID: https://orcid.org/0000-0003-0350-3482)
- Jan Klohs
- Raoul Seiler
Institutions
- University of Geneva (CH)
- University of Zurich (CH)
- ETH Zurich (CH)
- Institute for Biomedical Engineering (CH)
- Universitätsklinik Balgrist (CH)
- Geneva College (US)
Publication Details
- Journal
- Scientific Reports
- Published
- 2024-09-16
- DOI
- https://doi.org/10.1038/s41598-024-67389-9
- Citations
- 1
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- U.S. Department of Defense
- University of Southern California
- Alzheimer's Disease Neuroimaging Initiative
- Northern California Institute for Research and Education
- Olga Mayenfisch Stiftung
- National Institutes of Health